Acacia Pharma raises $23.5 million) in a string B financing led by Fidelity Biosciences and Novo A/S. Current investors Gilde Healthcare and Lundbeckfond Ventures participated in the round also. Dr Alex Pasteur of Fidelity Biosciences and Dr Martin Edwards of Novo A/S have joined the Plank of Acacia Pharma as Non-executive Directors. Acacia Pharma will use the proceeds to: total Phase III development of APD421 for preventing post-operative nausea & vomiting ; complete Phase II development of APD403 for the prevention of chemotherapy induced nausea & vomiting ; and develop the commercial display of APD515 for the treatment of xerostomia in advanced cancer patients.But do not forget to feel proud, too. Menstruation is an indicator of normal development and growth. Basically, you’re healthy and you’re growing up just how you should!
7 mysterious infections reported in Saudi Arabia, 5 dead RIYADH, Saudi ArabiaFive people have died from a SARS-like virus of unknown origin that has been circulating in the centre East since last April. Saudi Arabia’s Wellness Ministry said Thursday that five folks have died and two additional patients were in critical condition with confirmed cases of a new respiratory virus that’s called a coronavirus.